You are here

Article info

Article menu

Download PDFPDF

XML
Review
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies

Authors

  • Alberto Puccini University of Genoa, Medical Oncology Unit 1, Ospedale Policlinico San Martino IRCCS, Genova, Italy Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Francesca Battaglin Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Maria Laura Iaia University of Genoa, Medical Oncology Unit 1, Ospedale Policlinico San Martino IRCCS, Genova, Italy PubMed articlesGoogle scholar articles
  • Heinz-Josef Lenz Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Mohamed E Salem Department of Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mohamed E Salem; Mohamed.Salem{at}atriumhealth.org
View Full Text

Citation

Puccini A, Battaglin F, Iaia ML, et al
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
Journal for ImmunoTherapy of Cancer 2020;8:e000404. doi: 10.1136/jitc-2019-000404

Publication history

  • Accepted April 13, 2020
  • First published May 10, 2020.
Online issue publication 
May 10, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.